These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8103461)

  • 1. CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex.
    Lanza M; Fassio A; Gemignani A; Bonanno G; Raiteri M
    Eur J Pharmacol; 1993 Jun; 237(2-3):191-5. PubMed ID: 8103461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
    Gemignani A; Paudice P; Bonanno G; Raiteri M
    Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Mickel SJ; Bittiger H; Baumann PA
    Br J Pharmacol; 1994 Dec; 113(4):1515-21. PubMed ID: 7889310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Aminobutyric acid (GABA) autoreceptors in rat cerebral cortex and spinal cord represent pharmacologically distinct subtypes of the GABAB receptor.
    Bonanno G; Raiteri M
    J Pharmacol Exp Ther; 1993 May; 265(2):765-70. PubMed ID: 8388458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor.
    Fassio A; Bonanno G; Cavazzani P; Raiteri M
    Eur J Pharmacol; 1994 Oct; 263(3):311-4. PubMed ID: 7843269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex.
    Bonanno G; Raiteri M
    J Pharmacol Exp Ther; 1992 Jul; 262(1):114-8. PubMed ID: 1352547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex.
    Bonanno G; Fassio A; Schmid G; Severi P; Sala R; Raiteri M
    Br J Pharmacol; 1997 Jan; 120(1):60-4. PubMed ID: 9117099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptors.
    Bonanno G; Gemignani A; Schmid G; Severi P; Cavazzani P; Raiteri M
    Br J Pharmacol; 1996 Jul; 118(6):1441-6. PubMed ID: 8832070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of endogenous glutamic and aspartic acids from cerebrocortex synaptosomes and its modulation through activation of a gamma-aminobutyric acidB (GABAB) receptor subtype.
    Pende M; Lanza M; Bonanno G; Raiteri M
    Brain Res; 1993 Feb; 604(1-2):325-30. PubMed ID: 8096158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective block of rat and human neocortex GABA(B) receptors regulating somatostatin release by a GABA(B) antagonist endowed with cognition enhancing activity.
    Bonanno G; CaritĂ  F; Cavazzani P; Munari C; Raiteri M
    Neuropharmacology; 1999 Nov; 38(11):1789-95. PubMed ID: 10587094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of baclofen and the GABAB antagonist, CGP 35348, does not affect GABA, glutamate or aspartate in microdialysates of the striatum of conscious rats.
    Waldmeier PC; Stöcklin K; Feldtrauer JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):548-52. PubMed ID: 1356233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA(B) receptors as potential targets for drugs able to prevent excessive excitatory amino acid transmission in the spinal cord.
    Bonanno G; Fassio A; Sala R; Schmid G; Raiteri M
    Eur J Pharmacol; 1998 Dec; 362(2-3):143-8. PubMed ID: 9874164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro.
    Bon C; Galvan M
    Br J Pharmacol; 1996 Jun; 118(4):961-7. PubMed ID: 8799569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologically distinct GABAB receptor subtypes modulate neurotransmitter release in the rat brain cortex.
    Raiteri M; Bonanno G; Gemignani A; Pende M; Vellebuona F; Lanza M
    Adv Biochem Psychopharmacol; 1992; 47():205-16. PubMed ID: 1354915
    [No Abstract]   [Full Text] [Related]  

  • 15. Baclofen and phaclofen modulate GABA release from slices of rat cerebral cortex and spinal cord but not from retina.
    Neal MJ; Shah MA
    Br J Pharmacol; 1989 Sep; 98(1):105-12. PubMed ID: 2804540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices.
    Seabrook GR; Howson W; Lacey MG
    Br J Pharmacol; 1990 Dec; 101(4):949-57. PubMed ID: 1964824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.
    Teoh H; Malcangio M; Bowery NG
    Br J Pharmacol; 1996 Jul; 118(5):1153-60. PubMed ID: 8818338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of taurine on depolarization-evoked release of amino acids from rat cortical synaptosomes.
    Kamisaki Y; Maeda K; Ishimura M; Omura H; Itoh T
    Brain Res; 1993 Nov; 627(2):181-5. PubMed ID: 7905350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Aminobutyric acidB receptors mediate inhibition of somatostatin release from cerebrocortex nerve terminals.
    Bonanno G; Gemignani A; Fedele E; Fontana G; Raiteri M
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1153-7. PubMed ID: 1684816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.
    Schneider D; Schlicker E; Malinowska B; Molderings G
    Br J Pharmacol; 1991 Oct; 104(2):478-82. PubMed ID: 1665738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.